SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 284.75 |
| Enterprise Value ($M) | 332.57 |
| Book Value ($M) | -30.58 |
| Book Value / Share | -0.15 |
| Price / Book | -9.31 |
| NCAV ($M) | -154.14 |
| NCAV / Share | -0.74 |
| Price / NCAV | -1.85 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.71 |
| Return on Assets (ROA) | -0.19 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.03 |
| Current Ratio | 1.18 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 118.15 |
| Assets | 241.70 |
| Liabilities | 272.29 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 194.62 |
| Operating Income | -44.49 |
| Net Income | -51.92 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -23.38 |
| Cash from Investing | 0.00 |
| Cash from Financing | -25.21 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 4.04 | -32.31 | |
| 13G/A | Satter Muneer A | 8.60 | 7.39 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 412,301 | 1,877,001 | 21.97 | |
| 594,992 | 2,006,106 | 29.66 | |
| 599,436 | 660,506 | 90.75 | |
| 525,649 | 442,891 | 118.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AGEN – Agenus Inc. | AIMD – Ainos, Inc. |
| AKAN – Akanda Corp. | ALBT – Avalon GloboCare Corp. |
| ALDX – Aldeyra Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io